SAREPTA THERAPEUTICS, INC. Other Loans Payable
SAREPTA THERAPEUTICS, INC. (SRPT) had Other Loans Payable of $2.32 million as of 2017-09-30, per its 10-Q filed 2017-11-01.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Loans Payable
us-gaap:OtherLoansPayable · last filed 2017-11-01
- 2017-09-30: Other Loans Payable $2.32M.
- 2016-12-31: Other Loans Payable $1.37M.
| Period end | Other Loans Payable |
|---|---|
| 2017-09-30 | $2.32M 10-Q · filed 2017-11-01 |
| 2016-12-31 | $1.37M 10-Q · filed 2017-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |